SENP1-KLF4 signalling regulates LPS-induced macrophage M1 polarization

Kezhou Wang1, Jie Xiong2, Yiwen Lu3

  • 1Department of Pathology, Xinhua Hospital, Affiliated to Medicine School of Shanghai Jiaotong University, Shanghai, China.

The FEBS Journal
|August 9, 2022
PubMed

Insights

The SENP1-KLF4 axis is crucial for M1 macrophage polarization, impacting tumor cell activity. This pathway offers potential as a cancer therapy target.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Macrophages are key immune cells in tumor immunity, with M1 and M2 subtypes.
  • Krüppel-like factor 4 (KLF4) is essential for macrophage polarization.
  • KLF4 SUMOylation is important for M2 macrophage polarization.

Purpose of the Study:

  • To identify proteases involved in KLF4 de-SUMOylation.
  • To investigate the role of the SENP1-KLF4 axis in macrophage polarization and tumor immunity.
  • To explore the therapeutic potential of targeting the SENP1-KLF4 axis in cancer.

Main Methods:

  • Identification of small ubiquitin-like modifier (SUMO) specific peptidase (SENP)1 as a KLF4 de-SUMOylating protease.
  • Analysis of the SENP1-KLF4 axis in lipopolysaccharide-induced M1 macrophage polarization.
  • Assessment of the impact of KLF4 SUMOylation-deficient macrophages on tumor cell activity.

Main Results:

  • SENP1 was identified as a specific protease for KLF4 de-SUMOylation.
  • The SENP1-KLF4 axis plays a vital role in M1 macrophage polarization via the nuclear factor kappa B signaling pathway.
  • KLF4 SUMOylation-deficient macrophages exhibited weakened tumor cell activity.

Conclusions:

  • The SENP1-KLF4 axis is critical for regulating M1 macrophage polarization.
  • This axis influences tumor cell activity, suggesting its role in cancer progression.
  • Targeting the SENP1-KLF4 axis presents a potential therapeutic strategy for cancer treatment.